Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.25658 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.46785 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21581 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.20789 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.08688 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.27734 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.24597 | 49 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19826 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.38163 | 56 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.41952 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.2223 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.18325 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.02877 | 44 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.4971 | 58 |